FDA priority review for nivolumab
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

FDA priority review for nivolumab

› Forums › General Melanoma Community › FDA priority review for nivolumab

  • Post
Viewing 2 reply threads
  • Replies
      • September 27, 2014 at 3:15 pm
      JerryfromFauq
      Participant

      Thanks, hopefully it will be approved as a first line treatment withut too many restrictions.

       

      • September 27, 2014 at 3:15 pm
      JerryfromFauq
      Participant

      Thanks, hopefully it will be approved as a first line treatment withut too many restrictions.

       

      • September 27, 2014 at 3:15 pm
      JerryfromFauq
      Participant

      Thanks, hopefully it will be approved as a first line treatment withut too many restrictions.

       

        • September 28, 2014 at 4:56 pm
        mary1233
        Participant

        I hope that they do not require people to fail with ipi the way they did with the merck drug. The rate of success with ipi is fairly low, and yet with Keytruda the FDA requires that huge expense before the next huge expense. I do not understand our medical system.

        • September 28, 2014 at 4:56 pm
        mary1233
        Participant

        I hope that they do not require people to fail with ipi the way they did with the merck drug. The rate of success with ipi is fairly low, and yet with Keytruda the FDA requires that huge expense before the next huge expense. I do not understand our medical system.

        • September 28, 2014 at 4:56 pm
        mary1233
        Participant

        I hope that they do not require people to fail with ipi the way they did with the merck drug. The rate of success with ipi is fairly low, and yet with Keytruda the FDA requires that huge expense before the next huge expense. I do not understand our medical system.

Viewing 2 reply threads
  • You must be logged in to reply to this topic.
About the MRF Patient Forum

The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.